|
FAM171A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62903024403249E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-16 |
| Normal-vs-Stage2 |
6.36680000000167E-05 |
| Normal-vs-Stage3 |
4.76000017179956E-10 |
| Normal-vs-Stage4 |
1.65234492754962E-12 |
| Stage1-vs-Stage2 |
2.024400E-01 |
| Stage1-vs-Stage3 |
5.184600E-01 |
| Stage1-vs-Stage4 |
1.100630E-01 |
| Stage2-vs-Stage3 |
4.577200E-01 |
| Stage2-vs-Stage4 |
3.194300E-02 |
| Stage3-vs-Stage4 |
6.426500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.90478793533111E-14 |
| Normal-vs-AfricanAmerican |
4.32810010053686E-10 |
| Normal-vs-Asian |
3.18312043390279E-12 |
| Caucasian-vs-AfricanAmerican |
1.658830E-01 |
| Caucasian-vs-Asian |
1.519190E-01 |
| AfricanAmerican-vs-Asian |
6.000400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.52065035510896E-12 |
| Normal-vs-Female |
4.9960036108132E-15 |
| Male-vs-Female |
7.777400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
1.45439216225896E-14 |
| Normal-vs-Age(61-80Yrs) |
1.90179999526308E-08 |
| Normal-vs-Age(81-100Yrs) |
7.843900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.877200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.759840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.522800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.900200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.935000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.587000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.643400E-01 |
| Classical-VS-Follicular |
1.955190E-01 |
| Classical-VS-Other |
7.424000E-01 |
| Classical-VS-Normal |
2.32291963442322E-12 |
| Tall-VS-Follicular |
5.677000E-01 |
| Tall-VS-Other |
7.065200E-01 |
| Tall-VS-Normal |
7.05310000403969E-08 |
| Follicular-VS-Other |
5.197400E-01 |
| Follicular-VS-Normal |
6.81543710356891E-12 |
| Other-VS-Normal |
9.818400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19904086659517E-13 |
| Normal-vs-N1 |
3.76632058873838E-12 |
| N0-vs-N1 |
6.930500E-02 |
|
|
